EMCDDA webinar: Prevention of drug-related problems in the time of COVID-19: what can we learn?
The EMCDDA is offering a new series of webinars around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users, and those supporting them, are coping with the pandemic and to share knowledge and experience. The webinars will give a voice to key professionals working in the drugs field and will allow for a panel discussion on emerging challenges. The sessions, chaired by EMCDDA staff members, are open to EMCDDA employees, the Reitox network and professionals working in the domain.
In the trial phase, the webinars will vary in length and frequency and will be adjusted following participants’ evaluations. The agency is testing the webinar format as a new EMCDDA product type.
This third webinar takes place on 4 June on the theme of 'Prevention of drug-related problems in the time of COVID-19: what can we learn?' (13.00–14.30 CET – Brussels time).
A conversation with:
- Rosaria Galanti, Adjunct Professor, Department of Global Public Health, Karolinska Institutet, Sweden;
- Rachele Donini, Doctor Psychologist, Department of Mental Health and Addiction, ASL2 Savonese, Savona, Italy;
- Peer van der Kreeft, Lecturer in Prevention, University College of Ghent, Belgium.
Chairpersons: Gregor Burkhart, Marica Ferri, EMCDDA
Format: The format of the webinar is an informal chat, during which each panellist will talk in turn about how their ongoing activities are related to COVID-19. They will share their learning points so far and also try to imagine how the epidemic will change their work going forward ('the new normal').